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Stress responseEnvironmental stresses threatening cell homeostasis trigger various cellular responses ranging from the activation
of survival pathways to eliciting programmed cell death. Cellular stress response highly depends on the nature and
level of the insult as well as the cell type. Notably, the interplay among all these responses will ultimately deter-
mine the fate of the stressed cell. Human DExD/H RNA helicases are ubiquitous molecular motors rearranging
RNA secondary structure in an ATP-dependent fashion. These highly conserved enzymes participate in nearly all
aspects of cellular process involving RNA metabolism. Although numerous functions of DExD/H RNA helicases
are well documented, their importance in stress response is only just becoming evident. This review outlines
our current knowledge on major mechanistic themes of human DExD/H RNA helicases in response to stressful
stimuli, especially on emerging molecular models for the functional roles of these enzymes in the stress survival
regulation.
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Tomaintain homeostasis, eukaryotic cells must respond continuously
to ﬂuctuations in external conditions. Beyond a certain threshold, such
environmental changes can be considered ‘stresses’ to the cell. Stresses
can be further broadly classiﬁed into abiotic and biotic insults. Tempera-
ture shift, ultraviolet light, ion concentrations, pH, oxygen tension, redox
potentials and metabolite concentrations are common abiotic stress
conditions. Meanwhile, biotic stresses include perturbations caused by
various microbial pathogens.
Exposure to environmental stress can damage existing macromole-
cules, includingproteins,mRNAs, DNA and lipids. Therefore, in response
to sub-lethal stress, cells mount different defense mechanisms and
pro-survival strategies to adapt their metabolism, re-establish cellular
homeostasis and protect themselves against potential damage. These
stress responses are orchestrated through a multifaceted cellular
program, such as nutrient uptake, intermediary metabolism, induction
of molecular chaperones [1,2], rapid clearance of damaged macromole-
cules [3], cell cycle and growth control, cell fate and lineage decisions,
as well as activation of certain gene expression programs [4]. However,
if the stress remains unresolved, then the eventual cell death programs
are activated to eliminate these damaged cells [5]. Cell death is a neces-
sary part of tissue homeostasis enabling the removal of dysfunctional
cells. This phenomenon is not merely incidental during stress response
but, rather, a controlled andmodiﬁable complex process. In a multicellu-
lar organism, completion of the proper pathway is critical to ensure that
the appropriate outcome is ultimately achieved. Failure to die in response
to stress stimuli can result in tissue pathology, organ dysfunction and ini-
tiation of diseases. Nowadays, several types of programed cell death, such
as apoptosis, necrosis and autophagic cell death, are deﬁned and charac-
terized by distinct morphological and molecular features.
Among all the forms of cell death, apoptosis (or type I cell death) is
common to the vastmajority of physiological cell death and the best char-
acterized. The key apoptotic proteins, caspases, a cysteine endo-proteases
family, act as death effectors in apoptosis. Caspases are synthesized as in-
active zymogens that are subsequently activated by speciﬁc proteolytic
cleavage. The morphologic features of apoptotic cell death include
polynucleosomal DNA fragmentation, loss of overall cell shape, nuclear
shrinkage, and phagocytosis of cell fragments without accompanying in-
ﬂammatory responses [6]. Various cellular stress conditions have been
shown to trigger apoptosis, including irradiation, chemotherapeutic
agents, viral infection, oxidative and ER stress [5,7].
Autophagy (or type II cell death) is an evolutionarily conserved mul-
tistep catabolic process characterized by formation of autophagosomes,
double membrane-bound vesicles surrounding long-lived cytoplasmic
proteins and organelles, destined for recycling [8]. In recent years, au-
tophagy has received considerable attention due to its dual roles inmedi-
ating decisions between life and death. The ability of autophagy to recycle
old components makes it essential for normal cellular homeostasis and
stress adaptation to prevent cell death. However, to cope with excessive
stress, autophagic cells may commit suicide by undergoing a type of
caspase-independent cell death, which differs from apoptosis and pro-
grammed necrosis [9,10]. The molecular events eventually determining
the protective/destructive fate of autophagy remain elusive. Interestingly,
in certain conditions, apoptosis and autophagy can exert synergeticeffects, while under other circumstances inhibition of apoptosis can
trigger autophagic cell death [11,12]. Recent evidence suggests cross-
talk between apoptosis and autophagy at the molecular level [13].
Typically, autophagy is observed in cells that are exposed to various
metabolic and therapeutic stresses, including nutrient starvation,
growth factor deprivation, inhibition of the receptor tyrosine kinase/
Akt/mTOR (mammalian target of rapamycin) signaling, ischemia/
reperfusion, inhibition of proteasomal degradation, the accumulation
of intracellular calcium, and ER stress.
Necrosis (or type III cell death) refers to cell deaths morphologically
characterized by cytoplasmic granulation, organelle/cell swelling and cell
lysis. This lysis releases intracellular constituents, leading to an inﬂamma-
tory response provoked by immune cells. Necrotic cell death has been ob-
served in response to different harsh cellular stresses, including heat
shock, osmotic pressure, ischemia, glutamate excitotoxicity in neurons
or cancer cells exposed to alkylating DNA damaging agents [5]. For
many years, apoptosis was considered as the only form of regulated cell
death,whereas necrosiswasmostly considered as an accidental, random,
passive and uncontrolled process. However, recent evidence has greatly
changed this view and revealed the existence of ‘regulated necrosis’ con-
trolled by a set of signaling transduction cascades [14–17]. During the last
decade, additional cell death modes (such as necroptosis, parthanatos,
oxytosis, ferroptosis, ETosis, NETosis, pyronecrosis and pyroptosis) and
their underlying pathways have been characterized and classiﬁed. As
these cell death subroutines have been shown to share a necrotic mor-
phological hallmarks and to be responsive to speciﬁc pharmacological
or genetic interventions, these alternative cell death types with unique
features are proposed to be considered as different forms of regulated
necrosis [16,17]. For example, pyroptosis, initially introduced to describe
the atypical demise of macrophages infected by Salmonella enterica
serovar Typhimurium, is associated with anti-microbial responses during
inﬂammation and a cell death subroutine mediated by the activation of
caspase-1, but rather than depending on the classical apoptotic caspases
[18]. During pyroptosis, caspase-1 is activated by a large supramolecular
complex termed the inﬂammasome (also known as pyroptosome). In
addition to allowing for thematuration and secretion of the inﬂammatory
cytokines IL-1β and IL-18, the activation of caspase-1 also induces the for-
mation of the plasma membrane pores rapidly leading to osmotic cell
lysis, release of the cytosolic contents and cytokines that activate pro-
inﬂammatory immune cell mediators [18]. Moreover, pyroptotic cells un-
dergo DNA fragmentation with retained integrity and nuclear condensa-
tion, showing positive TUNEL staining.
In addition to the modes of cell death described above, it is well ac-
cepted that other pathways that have not yet been explored may exist.
In general, the dominant death pathway invoked by a particular stress
stimulus largely depends on the nature and level of the insult, the acti-
vation state or differentiation state of individual cells and the ability of
the stressed cell to handle the conditions to which it is exposed [5].
Interestingly, multiple types of death pathways could be activated in
single dying cells and crosstalk between these death programs may
allow ﬁne control over the ultimate outcome. Inhibiting the dominant
cell death route may not lead to cellular survival but, instead, induce
the alternate cell death programs [11–13]. Therefore, understanding
how these processes are interconnected could predict cellular suscepti-
bility to stresses and reveal novel therapeutic targets. Additionally,
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the characterization of novel pathways of cell death and further our un-
derstanding of the physiological and pathological processes underlying
a variety of human diseases. As a detailed description of these cell death
processes is beyond the scope of this article, we would like to refer the
reader to a number of excellent reviews that provide more in depth in-
sights into different forms of programmed cell death [6,8,10,16–20].
2. Human DExD/H RNA helicases
RNA helicases are highly conserved molecular motors that remodel
RNAor ribonucleoprotein (RNP) complexes in anATP-dependentmanner
[21–23]. With only a few exceptions, RNA helicase genes are encoded in
prokaryotic, archaea, eukaryotic and viral genomes [24]. These enzymes
are potentially associated with the entire lifespan of RNA, from transcrip-
tion and translation to degradation [22,24]. Indeed, a growing number of
these enzymes are linked with specialized regulatory processes, and
many of them are essential for viability. Although much remains elusive,
fascinating models are emerging to link structural, mechanistic, and
cellular function for RNA helicases in the last two decades.
On the basis of conserved sequence motifs and structural features,
nucleic acid helicases are broadly grouped into six superfamilies (SFs)
[25,26]. The monomeric helicases comprise SFs 1 and 2, while the olig-
omeric (mostly hexameric) ring-forming ones comprise SFs 3 to 6 [26].
As the ring-shaped RNA helicaseswill not be discussed here, readers are
referred to recent excellent reviews on these proteins [27,28].Meanwhile,
all eukaryotic RNA helicases belong to the largest groups, SFs 1 and 2.
These enzymes contain a structurally conserved helicase core, composed
of two tandemly repeated RecA-like globular domains (DOMAINS 1 and
2) (Fig. 1) that structurally resemble the bacterial recombinase A protein
(RecA) [29]. In terms of three-dimensional architecture, Domains 1 and 2
are connected by a ﬂexible linker region and form a conserved structural
fold facilitating themotor protein function associatedwith helicase activ-
ity. Within this helicase core, at least 12 characteristic motifs, so called
helicasemotifs Q, I, Ia, Ib, Ic, II, III, IV, V, Va, Vb andVI are arranged sequen-
tially and located at deﬁned positions (Fig. 1). These conserved motifs
comprise residues essential for ATP binding and hydrolysis (motifs Q, I,
II and VI), RNA binding and translocation (motifs Ia, Ib, Ic, IV, V and Vb)
and for coupling ATP hydrolysis to unwinding (motif III) [22,23,25,29,
30]. However, not all motifs are present in each helicase family, whereas
the levels of sequence conservation in these motifs are decreasing
among different families [25]. Notably, additional domains have been
identiﬁed in some helicases [31]. These accessory domains may rigidify
the relative position of Domains 1 and 2, providing an extensive RNA in-
terface and assisting in presenting RNA substrates to the helicase core
[30].
The conserved helicase core is surrounded by variable auxiliary
domains (Fig. 1). These C- and N-terminal regions are generally not
conserved within or between families [25]. These extended C- and
N-terminal domains are usually larger than the helicase core andbelieved
to confer functional speciﬁcity to individual helicases. For example, theseFig. 1. Structure of RNA helicase core in SF1 and SF2 proteins. The helicase core region of SF1 and
2) containing at least 12 conservedmotifs. The motifs are shownwith color according to their p
RNA-binding sites; blue, RNA binding). Notably, Motif Ib is not shared in all SF1 and SF2 families
served functional helicase core, most SF1 and SF2 helicases possess additional variable N- and C
The lengths of the motifs and the distance between the conserved domains are not drawn to s
The ﬁgure has been adapted from [22,23,25,29,30].ﬂanking regions have been shown to modulate enzymatic activity, to
facilitate recognition of speciﬁc nucleic acid regions or to provide docking
sites for protein–protein interactions [22,23,32].
The majority of RNA helicases belong to superfamily 2 (SF2) com-
prised of ﬁve subfamilies, further distinguished based on the amino
acid sequence of the conserved helicase motif II (DEAD, DEAH, DExH
andDExDhelicases) [25]. Of note, not only these RNAhelicases facilitate
RNA duplex separation, but also many of them catalyze strand ex-
change, strand annealing and RNA assembly/disassembly [22]. Biologi-
cally, the human DExD/H RNA helicases have a range of function in
nearly every cellular process associated with RNAmetabolism, including
pre-mRNA processing, ribosome biogenesis, RNA turnover, export, trans-
lation, surveillance, storage and decay [32,33]. It is now clear that human
DExD/H RNA helicases generally act as components of multi-protein
complex with additional ATP-independent roles presumably conferred
through their interactions with protein partners. Such complexity and
multi-functionality would allow DExD/H RNA helicases to integrate dif-
ferent processes in RNA metabolism.
3. DExD/H RNA helicase-mediated regulation of cell survival
under stress
As the human DExD/H RNA helicases participate in almost every
step of RNA metabolism, it is not surprising that these helicases play a
critical role in gene expression regulation during cellular stress re-
sponse. Indeed, emerging evidence demonstrates that human DExD/H
RNA helicases could act as hubs in the cellular networks to coordinate
cellular stress responses to maintain cellular homeostasis for survival
or to trigger cell death. In this review, we will attempt to summarize
recent advances in understanding of the molecular mechanisms that
enable human DExD/H RNAhelicases to sustain cell survival, coordinate
stress responses, andmediate cell death, especially focusing onmicrobial
pathogen-induced signaling cascades and stress granule formation
triggered by various stress stimuli. We apologize for the omission of a
large number of references that we could not include here due to
space limitations. In addition,wewould like to refer the reader to excel-
lent reviews that provide more in depth analysis of prokaryotic and
plant RNA helicases in stress response [34–36].
3.1. Defense against pathogen infections— cell death induction by DExD/H
RNA helicases
Various microbial pathogen infections impose different levels of
stress on the infected cells. During infections, pathogens are detected by
innate immune cells with the help of various receptors recognizing cer-
tain pathogen-derived conserved structures, known as pathogen-
associated molecular patterns (PAMPs) [37]. Pathogen-derived nucleic
acids, including their genomic RNA and DNA, as well as replication inter-
mediates and double-stranded RNA, have long been recognized as a
PAMP and detected by several cellular receptor proteins. These receptors
facilitate downstream signaling events to induce antiviral interferonSF2 RNA helicases consists of two RecA (recombinase A)-related domains (domains 1 and
rimary function (red, ATP binding and hydrolysis; yellow, coordination between NTP- and
. Green ribbons with asterisks indicate insertions of additional motifs. Apart from the con-
-terminal extensions that provide RNA/protein cofactor speciﬁcity to individual helicases.
cale.
Table 1
Cytoplasmic RNA helicases critical for sensing pathogen-derived nucleic acid.
Nucleic acid sensor Sensed pathogens Natural ligand Synthetic ligand Note Reference
RLR
RIG-I/Ddx58 (−)ssRNA virus, (+)ssRNA virus, dsRNA
virus, DNA virus, bacteria
Viral ss/dsRNA 5′ppp-dsRNA Positive regulator [62,65,163–173]
MDA5/Iﬁh1/Helicard (−)ssRNA virus, (+)ssRNA virus, dsRNA
virus, DNA virus
Viral long dsRNA Poly(I:C) Positive regulator [62,164,167,168,171,174–176]
LGP2/DHX58 (+)ssRNA virus dsRNA Negative/positive regulator [64–66,177]
Non-RLR helicases
DDX1/DDX21/DHX36 (−)ssRNA virus, dsRNA virus Viral dsRNA Poly(I:C) Positive regulator [79]
DDX3 (−)ssRNA virus Viral stem-loop RNA Poly(I:C) Positive regulator [72]
DHX9 (−)ssRNA virus, dsRNA virus dsDNA, dsRNA Poly(I:C) CpG-B ODNs Positive regulator [77,78]
DHX36 DNA virus dsDNA CpG-A ODNs Positive regulator [78]
DDX41 DNA virus Synthetic AT-rich B DNA Positive regulator [74]
DDX60 (−)ssRNA virus, DNA virus Viral ss/dsRNA; dsDNA Positive regulator [80]
DHX33 dsRNA virus, bacteria Viral dsRNA Poly(I:C) Positive regulator [81,82]
5′ppp, 5′ triphosphate end; dsRNA, double-stranded RNA; LGP2, Laboratory of Genetics and Physiology 2; MDA5, melanoma differentiation-associated protein 5; ODN,
oligodeoxynucleotide; poly(I:C), polyinosinic–polycytidylic acid; RIG-I, retinoic acid-inducible gene I; ssRNA, single-stranded RNA.
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interferon production and immune response, programmed cell death of
infected cells induced by these receptors is now being recognized as
another line of defense against microbial pathogens [38–42]. Since path-
ogen propagation requires a functional host metabolism, death of host
cell could interfere the replicative cycle of pathogens, expose the patho-
gen to extracellular immune surveillance andpromote activation of adap-
tive immune system by presenting microbial antigens to T cells [43,44].
Accordingly, to diminish the replicative niche of pathogens, pro-survival
defensemechanisms need to be ﬁne-tunedwith cellular suicide program
in response to pathogen infections.
In recent years, it has emerged that several DExD/H-box RNA
helicases contribute to anti-pathogen immunity and cell survival regula-
tionuponpathogen infection. Oneof themain groups of receptors sensing
pathogen-derived nucleic acids is the RIG-like receptors (RLRs),which are
part of the DExH-box RNA helicases [45,46]. In addition to RLRs, numer-
ous DExD/H-box helicases have recently been implicated in the sensing
of pathogen-derived nucleic acids and/or facilitating downstream signal-
ing events to induce interferon production, immune responses or cell
death [46–49]. Here, we summarize the current knowledge on DExD/H
RNA helicases in defense against pathogen infections and their functional
role in cell fate decision. Table 1 contains a list of knownpathogen targets,
natural and synthetic ligands of these receptors.
3.1.1. RIG-I-like receptors (RLRs)
The RIG-I-like receptors (RLRs) are cytosolic proteins recognizing
pathogen-derived nucleic acid species. In resting, these proteins are
expressed at low levels in most cell types. However, upon stimulation
by pathogen-derived nucleic acids, RLRs are induced to high levels. RLRs
belong to the family of DExH-box helicases and include three members:
RIG-I (retinoic acid-inducible gene I), MDA5 (melanoma differentiation-
associated antigen 5) and LGP2 (Laboratory of Genetics and Physiology
2). Structurally, RLRs are related to each other (Fig. 2A). RLRs contain
the central helicase core region comprising the conserved two RecA-like
domains and a C-terminal regulatory domain (CTD) whichmediates spe-
ciﬁc recognition of nucleic acids [50,51]. Of note, RIG-I and MDA5 harbor
CARD (cysteine-aspartic protease (caspase)-recruiting domain) for inter-
action with the mitochondrial CARD-domain containing adaptor IPS-1
(IFNB-promoter stimulator 1; also known as MAVS, CARDIF and VISA;
Fig. 2A andB). The binding of RLR to RNA ligands results inATPhydrolysis,
along with RLR oligomerization and translocation to mitochondria, pro-
moting RLR interactionwith IPS-1 (Fig. 2B). These interactions further in-
duce phosphorylation of IRF3/7 by the IKK-related kinases TBK1 and IKKε,
leading to activation of these transcription factors and the downstream
expression of type I IFNs and pro-inﬂammatory cytokines. Subsequent
type I IFN signaling triggers a potent antiviral response deﬁned by the
rapid induction of hundreds of IFN-stimulated genes. These genes encodeproteins that conﬁne viral infection through regulation of cellular meta-
bolic activity, modulation of inﬂammation and/or eliciting apoptosis.3.1.1.1. RIG-I (retinoic acid-inducible gene I; also known as DDX58). RIG-I
harbors an ssRNA/dsRNA-binding C-terminal domain (CTD) which
functions as a repressor domain (RD) when unbound to RNA ligands
(Fig. 2A). The prototypical RIG-I ligand is short RNA with an uncapped
5′ triphosphate end and blunt-ended base pairing. In addition, RIG-I
has been shown to bind to various dsRNA and ssRNA ligands [52,53].
Consistentwith this notion, RIG-I has been demonstrated to be involved
in the recognition of various viruses, including antisense (−)ssRNA
viruses or sense (+)ssRNA/dsRNA viruses [54]. Moreover, RIG-I could
be indirectly activated by cytosolic viral and bacterial double-stranded
DNA (dsDNA), as these pathogen AT-rich dsDNA can be transcribed
by RNA polymerase III to generate dsRNA with 5′ triphosphate ends
[55,56].
Recent structural studies have provided a better understanding of
ligand binding and activation of RIG-I. Speciﬁc binding of 5′ppp is medi-
ated by the CTDwhereas the helicase domain binds the double-stranded
part of the RNA. In the inactive state, RIG-I is held in an auto-repressed
conformationwithunexposedCARD. Ligandbinding results in the release
of the two repeats of CARD at the N terminus. These conformation chang-
es enable RIG-I to interact with CARD-containing adaptor protein IPS-1
located at the cytosolic face of the outer mitochondrial membrane
(Fig. 2B). Thismitochondrial association is necessary for triggering subse-
quent downstream signaling events [57,58]. In addition, RIG-I could in-
teract with the adaptor protein ASC, resulting in inﬂammasome-
dependent caspase 1 activation and the subsequent pyroptosis (Fig. 2B)
[42]. RIG-I, but not MDA5, was also shown to interact with STING (stim-
ulator of IFN genes; also known as MITA, MPYS and ERIS), which is an
adaptor protein predominantly found in the endoplasmic reticulum [59,
60]. This interaction potentiates RIG-I-mediated signaling through TBK1
following RNA virus infection (Fig. 2B).3.1.1.2. MDA5 (melanoma differentiation-associated antigen 5; also known
as IFIH1).MDA5 has been implicated in the response to long dsRNA. It
has also been suggested that MDA5 recognizes particularly large and
branched RNA structures generated during the viral replication [61].
Compared with RIG-I, MDA5 seems to mediate responses to distinct
sets of viruses. However, MDA5 has also been shown to be of impor-
tance in cooperation with RIG-I during the antiviral response [62].
MDA5 is structurally homologous to RIG-I (Fig. 2A). Similarly to RIG-I,
upon binding of long dsRNA fragments,MDA5 exposes its CARD and ini-
tiates subsequent cytokine and type I IFN production through interac-
tion with IPS-1 (Fig. 2B) [63].
Fig. 2. Pathogen-derived nucleic acid-sensing and responsive machinery composed of cytoplasmic RNA helicases. (A) Structure of the RIG-I like receptors (RLRs) and their adaptor IPS-1.
RLRs are cytosolic proteins and structurally related to each other. These proteins harbor three key structural domains: (1) the two N-terminal tandem caspase activation and recruitment
domains (CARDs), present in RIG-I and MDA5 but absent in LGP2, are required for interaction with IPS-1 and downstream signaling. (2) The central helicase domain involved in RNA
binding, translocation/unwinding of RNA and ATP hydrolysis required for RLR function. (3) The unique C-terminal domain (CTD) containing a repressor domain (RD) involved in
auto-regulation. MDA5 lacks the RD. The adaptor IPS-1 consists of a transmembrane domain (TM) on its C-terminus, a proline-rich region (Pro) and the CARD for interaction with
RIG-I and MDA5. (B) Overview of the nucleic acid-sensing RLRs and non-RLR RNA helicases in cell survival regulation during pathogen infections. In the cytosol, the microbial
pathogen-derived nucleic acids could be recognized by various receptors, including the RIG-I-like receptors (RLRs) and some other DExD/H-box helicases. These receptors could induce
the expression of pro-inﬂammatory cytokines/type I IFNs or trigger inﬂammasome formation to promote a potent antiviral response through activation of various signaling cascades,
whichmay eventually lead to apoptosis or pyroptosis. RLRs are structurally conserved to each other. RIG-I recognizes ss- and ds-viral RNAs, whereasMDA5 responds to highly structured
ssRNA and dsRNA species. LGP2 has been proposed as both a positive and a negative regulator of RIG-I andMDA5 signaling. The two N-terminal CARD regions, present in RIG-I andMDA5
but absent in LGP2, are required for interaction with IPS-1 and downstream IPS1-mediated activation of TBK1 and IKKε and subsequent activation of transcription factors IRF3, IRF7 and
NFκB. Additionally, RIG-I may interactwith the adaptor protein ASC, leading to inﬂammasome-dependent caspase 1 activation and a following pro-inﬂammatory formof cell death called
pyroptosis. RIG-I was also shown to interactwith STING (stimulator of IFN genes), an adaptor protein located in the ER. This interaction potentiates TBK1-mediated RIG-I signaling. DDX60
has been proposed to sensitize the RLRs to viral ssRNA, dsRNA as well as dsDNA ligands through association with RIG-I, MDA5, and LGP2 but not with IPS-1. The proposed cytosolic DNA
receptors DDX41 interact with STING and TBK1 to activate TBK1, IKKε and the IKK complex. DHX9 has been proposed to sense dsRNA and trigger an IPS-1-dependent signaling. In addi-
tion, DHX36 and DHX9 activate TRIF-dependent and MYD88-dependent signaling in response to CpG-A and CpG-B DNA, respectively. DDX1, DDX21 and DHX36 have been suggested to
detect dsRNA and form a TRIF-interacting complex. DHX33 has been proposed to sense viral and bacterial RNA to activate NLRP3-dependent or STING-dependent signaling. DDX3 has
been reported to be a signaling adaptor through its interaction with TBK1 and IKKε. DDX3 has also been suggested to act as a sensor of viral RNA in conjunction with the RIG-I and
MDA5. Notably, DDX3 was demonstrated to be recruited to the IFN promoter, suggesting its transcriptional regulator role during infections.
The ﬁgure has been adapted from [46–49].
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DHX58). LGP2 is the third member of the RLRs and less well-
characterized. The LGP2 contains a similar helicase core and CTD as
RIG-I and MDA5, but lacks the CARD region present in RIG-I and
MDA5 (Fig. 2A). As the CARD region is responsible for the associationwith IPS-1 and the following signaling events, LGP2 is initially thought
to be a negative regulator of RLR signaling via interaction between the
RD region of LGP2 and that of RIG-I (Fig. 2A) [64,65]. However, both
positive and negative effects have been observed in recent reports, de-
pending on the exact nature of the RNA ligand, the virus studied and
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modulator of the innate immune response, but not a sensor due to its
incapability to initiate antiviral gene expression. Interestingly, LGP2
has been shown to enhance MDA5-dependent IFN induction and to
bind dsRNA independent of 5′-triphosphates [67]. Given that the afﬁnity
of the MDA5 CTD for dsRNA is relatively low, LGP2 might serve as a co-
receptor enhancing the ability of MDA5 to sense long dsRNA structures
by complexingwithMDA5 [67]. Itwill requiremore investigations to un-
derstand how LGP2 modulates RIG-I-dependent responses to different
RNA ligands and MDA5-mediated recognition of dsRNA.
3.1.2. Non-RLR helicases
In addition to RLRs, several other DExD/H-box helicases, including
DDX3, DDX60, DDX41, DDX1, DDX21, DHX9, DDX33 and DHX36, have
recently been implicated as additional receptors for pathogen-derived
nucleic acids and to induce downstream signaling and programmed
cell death (Fig. 2B). Interestingly, as mentioned above, many of these
helicases contain auxiliary variable N- and C-terminal regions conferring
their functional speciﬁcities, such as the ability to bind speciﬁc RNA
targets or to induce downstream signaling through protein/protein in-
teraction [46–48].
3.1.2.1. DDX3/DDX3X/DBX/CAP-Rf. Human DDX3 is a ubiquitously
expressed RNA helicase. DDX3 gene is located on the X chromosome
and is highly homologous to DBY, which is present on the Y chromosome
and only expressed in themale germ line [68]. The signaling adaptor role
of DDX3 in anti-viral innate immune signaling pathways has been pro-
posed in two reports [69,70]. DDX3 was identiﬁed as an interacting
partner and phosphorylation substrate of TBK1 (TANK-binding kinase
1), a central kinase for the induction of interferon in response to patho-
gens. DDX3 knockdown impairs interferon production whereas TBK1-
mediated phosphorylation of DDX3 is required for DDX3 to synergize
with TBK1 to stimulate the IFN promoter, suggesting that DDX3 is a crit-
ical TBK1 effector necessary for IFN induction [69] (Fig. 2B). Additionally,
DDX3 was demonstrated to be recruited to the IFN promoter, highlight-
ing its possible transcriptional regulator role after TBK1 activation [69]
(Fig. 2B). Another report demonstrated an interaction between DDX3
and IKKε [70] (Fig. 2B). Notably, DDX3 enhanced IFN promoter induction
by TBK1/IKKε in an ATPase and RNA unwinding activities-independent
manner [70]. However, the unique N-terminal fragment of DDX3was re-
quired for this activity [70]. As DDX3was identiﬁed as a host target of the
vaccinia virus (VACV) protein K7 in the samework, the authors proposed
that K7 forms a complex with DDX3 and antagonizes TBK1/IKKε-
mediated IFN-beta promoter activation to inhibit IFN-beta induction
[70]. Recently, the same research group conﬁrmed the direct DDX3/
IKKε interaction and identiﬁed the requirement of IKKε-mediated
DDX3 phosphorylation at serine 102 for the recruitment of IRF3 into
the complex, IRF3 activation as well as IFN promoter induction [71]
(Fig. 2B). Therefore, these ﬁndings propose DDX3 as a scaffolding adaptor
coordinating the activation of IKKε and IFN induction.
More recently, Oshiumi et al. demonstrated an interaction between
DDX3 and IPS1 and suggested that DDX3might directly bind to vesicular
stomatitis virus (VSV) RNA in conjunction with RIG-I and MDA5 to
enhance the IFN-I response, supporting a regulatory role of DDX3 in the
RLR pathway [72] (Fig. 2B). Also noted, DDX3 is targeted by vaccinia
virus protein K7 [70] and HCV core protein [73] to abrogate DDX3-
enhanced IPS-1 signaling. Collectively, these ﬁndings underscore the rel-
evance of DDX3 in efﬁcient sensing of pathogen-derived nucleic acids.
3.1.2.2. DDX41. DDX41 was shown to bind speciﬁcally to DNA rather
than RNA. This binding was further mapped to the DEAD domain of
DDX41 [74]. In addition, DDX41 could directly interact with TBK1 and
STING, a crucial adaptor molecule for cytoplasmic DNA receptors, but
not IPS1 [74] (Fig. 2B). Indeed, silencing of DDX41 expression in murine
myeloid dendritic cells (mDCs) led to amarked decrease of IFN and pro-
inﬂammatory cytokine production in response to cytosolic DNA [74].Another recent report conﬁrmed the DNA receptor role for DDX41
during adenovirus infection in the murine macrophage cell line [75].
Collectively, these ﬁndings identify DDX41 as an additional intracellular
STING-dependent DNA sensor for pathogenic DNA. Notably, DDX41 has
also been demonstrated to recognize bacterial secondary messenger
molecules cyclic di-GMP and cyclic di-AMP (cyclic dinucleotides; CDNs)
and form a complex with STING to activate the interferon response,
highlighting its importance in innate immune response [76].
3.1.2.3. DHX9/RNA Helicase A (RHA)/Nuclear DNA Helicase II (NDHII). In
myeloid dendritic cells (mDCs), DHX9 is required for the production
of pro-inﬂammatory cytokines and IFNα/β in response to inﬂuenza
virus, reovirus and poly(I:C) (polyinosinic–polycytidylic acid, a sub-
strate used as a mimic of viral dsRNA) [77]. Interestingly, DHX9 binds
dsRNA via its two N-terminal dsRNA-binding domains, whereas its
C-terminus interacts with the CARDs of IPS-1, linking DHX9 into the
RLH signaling pathway [77] (Fig. 2B). In addition, DHX9 is required for
the activation of NF-κB and IFN regulatory factor 3 by dsRNA, suggesting
an IPS-1-dependent RNA sensor role for DHX9 in pathogenic RNA-
sensing. It is worthy to note that DHX9 is recruited by various viruses
[46], suggesting that DHX9, like DDX3, may have a dual function as an
essential host cofactor for viral replication and an innate immunemedi-
ator in the battle between viruses and the host immune system.
3.1.2.4. DHX9 and DHX36 as CpG sensors. In addition to the dsRNA sen-
sor role of DHX9 mentioned above, DHX9 has also been identiﬁed in
plasmacytoid dendritic cells (pDCs) as a sensor for CpG DNA [78].
CpG DNA (or CpG ODN) are oligodeoxynucleotides containing
immunostimulatory unmethylated dinucleotide CpG motifs. These
motifs are considered pathogen-associated molecular patterns
(PAMPs) due to their abundance in microbial genomes and their rarity
in vertebrate genomes. DHX9 was shown to bind CpG-B, whereas
DHX36was characterized as a CpG-A binding protein [78]. Interestingly,
DHX36 binds CpG-A via the helicase domain, while DHX9 interacts with
CpG-B through its C-terminal region [78]. Also noted, DHX9 is associated
with TNFα and IL-6 production as well as NFκB activation in re-
sponse to CpG-B, but DHX36 is important for IFNα production in re-
sponse to CpG-A. As both helicases activate the cytosolic adapter
protein MyD88 (myeloid differentiation primary response gene 88)
through binding to its TIR (Toll-interleukin receptor) domain, these ob-
servations demonstrate that DHX9/DHX36 represent the MyD88-
dependent DNA sensors in pDCs (Fig. 2B).
3.1.2.5. DDX1/DDX21/DHX36 complex. In myeloid dendritic cells (mDCs),
another viral sensing complex consisting of RNA helicase DDX1, DDX21
and DHX36 has been identiﬁed by isolation of poly(I:C)-binding pro-
teins [79]. In response to poly(I:C), this DDX1/DDX21/DHX36 complex
triggers an antiviral program dependent of the adapter molecule TRIF
(TIR-domain containing adapter-inducing interferon-β). Intriguingly,
only DDX1 directly bound to poly(I:C) via its helicase domain, whereas
both DHX36 and DDX21 bind the TIR domain of TRIF [79] (Fig. 2B). This
complex was shown to be required for the IFN induction in response to
long or short poly(I:C), inﬂuenza and reovirus infection [79].
3.1.2.6. DDX60.DDX60 localizes at the cytoplasmic region and its expres-
sion could be induced upon viral infection [80]. Intriguingly, DDX60
could bind viral ssRNA, dsRNA as well as dsDNA [80], enhancing the
IFN response to RNA/DNA viruses and DNA stimulation through associ-
ation with RIG-I, MDA5, and LGP2 but not with IPS-1 [80]. Thus, DDX60
is proposed to act as a cofactor promoting RIG-I-like receptor-mediated
signaling (Fig. 2B).
3.1.2.7. DHX33. In innate immune responses, the NLRP3 (NLR Pyrin-
domain containing 3)-induced inﬂammasome plays a critical role by ac-
tivating caspase-1, resulting in secretion of IL-1β and IL-18. Recently,
RNA helicase DHX33 was identiﬁed as a cytosolic RNA receptor able to
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(Fig. 2B). DHX33 is involved in the activation of caspase-1 and secretion
of IL-1β/IL-18 induced by cytosolic poly(I:C), reoviral RNA or bacterial
RNA [81]. Notably, DHX33 was shown to bind dsRNA and NLPR3
through its helicase C domain and DEAD domain, respectively [81]. In
agreement with these ﬁndings, another recent study conﬁrmed the
role of DHX33 in the sensing of cytosolic poly(I:C) and reoviral RNA in
myeloid DCs [82]. However, in this report, poly(I:C)-induced activation
of NF-κB and IRF3 was demonstrated to be mediated by the interaction
betweenDHX33 and IPS-1,whichwasmapped to the helicase C domain
of DHX33 [82].
To ensure viral replicative niche, many viruses have evolved strate-
gies for interfering with the potent anti-viral effect of type I interferons.
Numerous examples of viral immune evasion proteins and strategies
have been reported, including masking of viral RNA ligands and direct
inhibition of nuclei acid receptors mentioned above [83]. Most intrigu-
ingly, numerous viruses rely greatly on host RNA helicases to mediate
RNA remodeling events during their replication cycle. Consistent with
this notion, several DExD/H-box helicases have been identiﬁed as essen-
tial host factors for the viral replication [46]. For example, DDX3 has been
shown to be essential for the replication of several viruses, including the
most famous HCV and HIV [46,84–86]. Similarly, DDX1 and DHX9 are re-
quired for the replication of various viruses [46]. Thus, the host RNA
helicases utilized by viruses may also be the very same ones implicated
in anti-viral innate immune responses. Future investigation on this ongo-
ing co-evolutionary combat between host and viruses would lead to new
insights into the host anti-viral immune response and cell death.
3.2. Stress granule formation to suppress apoptosis under stress
3.2.1. Translation silencing, stress granule assembly and cell survival
upon stress
Cells have evolved multiple strategies to cope with various environ-
mental insults, such as oxidative, genotoxic, hyperosmotic, heat shock
and viral infection. The cellular response to these stresses involves a global
silencing of protein translation. One hallmark of the stress response re-
ported recently is the temporary formation of large cytoplasmic RNP
foci, known as stress granules (SGs) [87–91].
3.2.1.1. Translational regulation and stress granule formation. Translational
regulation plays a central role in the control of gene expression. Under
most circumstances, recruitment of ribosomes to mRNA is the rate-
limiting step in translation initiation and a primary target for translational
control [92]. This process is facilitated by numerous eukaryotic initiation
factors (eIFs). One of these, eIF4G, an essential scaffold protein, is a sub-
unit of the hetero-trimeric eIF4F complex associating with the mRNA
m7G cap and facilitating ribosome joining to the mRNA. Two other com-
ponents of eIF4F complex are the cap-binding protein eIF4E and the RNA
helicase eIF4A. Additionally, eIF4G interacts with the poly(A) binding
protein (PABP), which stimulates initiation factor recruitment to mRNA
and leads to mRNA circularization [93,94]. The PABP–eIF4G interaction
is required for efﬁcient translation, and it stimulates the formation of
both 48S and 80S ribosome complexes [93].
In response to environmental stress (e.g., heat, oxidative conditions,
UV irradiation, and hypoxia), aggregates of stalled translation initiation
complex localize to cytoplasmic foci called stress granules (SGs) [87,90,
95]. SGs have been observed in various species and reported in vivo [87,
88,91]. Although the composition may vary with stress stimuli and cell
type [87,89], SGs typically harbor most components of the stalled 48S
pre-initiation complex (i.e., small ribosomal subunits, mRNA tran-
scripts, eIF3, eIF4A, eIF4E, eIF4G, eIF2, eIF2B and PABP1). These core con-
stituents of SGs are universal markers for all SGs. In addition, many
other protein components, including RNA helicases, RNA-binding pro-
teins, transcription factors, translation regulators and signaling mole-
cule have been reported to accumulate in SGs [87–89]. The selective
SG recruitment of both stabilizing and destabilizing proteins supportsa model in which these dynamic cytoplasmic foci are sites of mRNA
triage during stress.
Apart from stalled translation initiation during a stress response, SG
formation could be induced by pharmacological inhibition of translation
initiation, knockdown of speciﬁc initiation factors, or overexpression of
translational repressors [88]. However, not all initiation obstruction in-
duces SGs, suggesting that SG assembly occurs upon certain impeded ini-
tiation processes. Interestingly, several SG-associated proteins promote
SG assembly when overexpressed (e.g., TIA-1 or TIAR, G3BP, CPEB,
FAST, FXR1 and FRM), whereas other proteins have no effect or inhibit
SG assembly [87]. These ﬁndings indicate that ‘primary aggregation’ is
probablymediated by these SGnucleators that initiatemRNP aggregation
and thus physically nucleate SG assembly.
In addition, SGs are closely linked to another RNP granule, processing
body (PB), cytoplasmic mRNA degradation machinery [96]. These ﬁnd-
ings therefore raise a model in which SGs serve as triage centers that
sort, remodel, and export speciﬁc transcripts for re-initiation, storage, or
decay [87–89]. Most notably, SGs are highly dynamic structures and re-
cently proposed to act as signaling hubs by intercepting a group of signal-
ing molecules to modulate metabolism, growth and survival upon stress
[97]. Despite recent progress, a complete list of SG components is still
lacking. Thus, a deeper insight into the nature of themRNPcomplexwith-
in SGs would provide a better view of their function.
3.2.1.2. Stress granules and apoptosis. In addition to being critical for
mRNA regulation during stress, SGs modulate the signaling balancing
apoptosis and cell survival. Accumulating evidence reveals that stress
granule assembly and apoptotic cell death tend to occur in a mutually
exclusive fashion. Interventions preventing stress granule formation,
such as knockout of SG proteins, render cells more vulnerable to stress,
highlighting the cyto-protective role of SGs against environmental
insults [88]. Although the precise mechanism underlying how SGs
inhibit apoptosis has not been fully elucidated, recent reports pro-
vided evidence of the crosstalk between SG assembly and apoptosis
(Fig. 3).
One emerging scenario of the protective effect of SGs is the sequestra-
tion of pro-apoptosis factors into SGs to nullify their activities. The ﬁrst
case reported is the TRAF2 (TNF receptor-associated factor 2), a central
signaling molecule in TNF-α-mediated NF-κB pro-inﬂammatory signal-
ing. Upon treatment with various stress-inducing agents (heat shock,
arsenite, puromycin [polysome destabilizer] and FCCP [a chemical uncou-
pler of electron transport and oxidative phosphorylation]), TRAF2 is se-
questered in to SGs. Under heat stress, TRAF2 is retained in SGs through
the interaction with SG component eIF4G, resulting in the blockage of
TRAF2-mediated TNF signaling and downstream pro-inﬂammatory
responses responsible for cell death [98] (Fig. 3). Similarly, several key
molecules facilitating the MAPK/JNK apoptotic pathway, such as RACK1
(The Receptor for Activated C Kinase 1), ROCK1 (Rho-associated, coiled-
coil containing protein kinase 1), small GTPase RhoA (Ras homolog
gene family member A) and WDR62 (WD repeat domain 62) were
shown to be sequestered into SGs induced by heat shock or arsenite
[99–101], thereby protecting cells from apoptosis (Fig. 3). More recently,
an essential negative regulator of mTORC1 (mammalian target of
rapamycin complex 1) in the cellular stress response, astrin, was identi-
ﬁed. Under stress conditions, astrin recruits themTORC1 component rap-
tor to SGs, thus inhibiting mTORC1 association and avoiding mTORC1-
hyperactivation-induced apoptosis [102] (Fig. 3).
Another cell survival mechanism of SGs is linked to reactive oxygen
species (ROS) production. A recent study reported that SGs harbor anti-
oxidant activity, partly mediated by two SG components, G3BP1
(GTPase-activating protein SH3 domain binding protein 1) and USP10
(ubiquitin-speciﬁc protease 10) [103]. USP10 possesses an antioxidant
activity. However, under steady-state conditions, its activity is sup-
pressed by excess G3BP1. Upon stress, G3BP1 and USP10 cooperatively
induce SGs. Meanwhile, SGs disrupt G3BP1-mediated inhibition against
USP10, possibly by altering the conformation of USP10 and/or G3BP1,
Fig. 3. Cell survival mechanisms linkedwith SG formation. SGs have been shown to suppress apoptosis by various mechanisms: (a) upon heat stress or arsenite treatment, several central
molecules facilitating the MAPK/JNK apoptotic pathway, such as RACK1, RhoA, ROCK1, TRAF2 and WDR62 were retained in SGs, and thereby nullify their activities and protect
cells from apoptosis. (b) Under stress conditions like heat shock or arsenite, astrin recruits the mTORC1 component raptor to SGs, thus inhibiting mTORC1 association and avoiding
mTORC1-hyperactivation-induced apoptosis. (c) SGs have antioxidant activity, partly mediated by two SG components, G3BP1 and USP10. USP10 possesses an antioxidant activity; however,
its activity is suppressed by excess G3BP1 under steady-state conditions. Upon ROS stress, SGs disrupt G3BP1-mediated inhibition against USP10 probably through altering the conformation,
thereby uncovering the antioxidant activity of USP10 to reduce ROS production and protect cells from ROS-dependent apoptosis.
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production [103]. The authors proposed that SGs may act as rapidly
inducible antioxidant machinery protecting cells from ROS-induced
apoptosis [103] (Fig. 3).
An additional interesting possibility is that SG assembly is required
for optimal translation of stress-responsive mRNAs. When canonical
cap-dependent translation is compromised during stress, those
mRNAs preferentially translated under these conditions tend to initiate
translation by non-canonical mechanisms and their translation upon
stress largely depends on uORF (upstream open reading frame) and
IRES (internal ribosome entry site) [104–108]. Recent estimates suggest
that 10–15% of cellular transcripts possess IRES activity, whose transla-
tion may ﬂuctuate depending on the stress condition [106]. Both uORF
and IRES rely on various trans-acting factors, such as eIF3 [109],
hnRNP A1 [110] and PCBP2 [111]. Interestingly, these factors are critical
SG components, supporting that translation initiation of speciﬁcmRNAs
may require SG formation and even occur in SGs.
Moreover, SGs were reported to be associated with the stability of
certain mRNAs, such as ARE-containing mRNAs. The AREs (AU-rich
elements), prominent instability cis-acting elements within the 3′
untranslated regions of unstable mRNAs, direct rapid mRNA decay
process named ‘ARE-mediatedmRNAdecay (AMD)’ and are responsible
for the rapid decay of many short-lived mRNAs including cytokines,
growth factors, and proto-oncogenes. In addition to the AREs, the
AMDpathway involves trans-acting factors known as ARE-binding pro-
teins (ARE-BPs) that positively or negatively affect the AMD process.
Most remarkably, numerous ARE-BPs were recruited into SGs upon
stress [90,112]. Because SGs contain proteins involved in both degrada-
tion and stabilization of mRNAs, their assembly might be critical for the
regulation of mRNA decay during stress [90,112]. Indeed, current
knowledge indicates that SGs do affect the stability of an array of
stress-responsive mRNAs, including ARE-containing messages p21
mRNA, with consequences on cell survival [113]. Thus, SG-mediated
reprogramming of mRNA translation and decay assembly may reconﬁg-
ure the proteome to facilitate cellular adaption to adverse environmental
conditions.Collectively, the role of SGs in controlling apoptosis could be linked
to sequestration of apoptosis-promoting factors, suppression of ROS
production and reprogramming of mRNA expression upon stress.
3.2.2. Stress granule-associated RNA helicases
Considering the various RNA remodeling processes occurring in SGs,
it is unexpected that only a few RNA helicases were found to be associ-
atedwith these foci (Table 2). And it will be no surprise if the number of
RNA helicases associated with SGs is revealed to be much more. Here
we summarize the relevance of these SG-associated RNA helicases in
SG assembly, reprogramming of gene expression and cellular survival
regulation during stressed conditions.
3.2.2.1. DDX1. RNA helicase DDX1 associates with poly(A) RNA [114]
and is present in RNA-transporting granules [115]. When subjected to
arsenite stress, DDX1 was found to colocalize with YB-1 and MBNL1
(muscleblind-like splicing regulator 1) at cytoplasmic stress granules,
suggesting a role for these three proteins in mRNA metabolism in the
cytoplasm during stress [116]. In addition, DDX1was found in the cyto-
plasmic PQBP1 (polyglutamine-binding protein 1) protein complex and
co-localized with PQBP1 in SGs upon arsenite-induced oxidative stress
[117]. As PQBP1 has been linked to several X-linked intellectual disability
disorders and progressive neurodegenerative diseases, these ﬁndings
may suggest a role for DDX1 in cellular survival regulation during the
pathogenesis of intellectual disability.
Most recently, the interaction betweenDDX1and another component
of PQBP1 complex, KSRP (K homology Splicing Regulatory Protein), was
further characterized [118]. KSRP is a decay-promoting ARE-binding pro-
tein and predominately localizes in the nucleus. Previously, KSRP has
been reported to be phosphorylated by AKT and this phosphorylation
enhances its interaction with 14–3–3ζ, rendering its localization to the
nucleus [119]. Under oxidative stress, KSRP accumulates in SGs and colo-
calizeswithDDX1 [117]. Interestingly, down-regulation of DDX1 elevated
cytoplasmic levels of KSRP and facilitated ARE-mediated mRNA decay
[118]. As DDX1 could compete with 14–3–3 for interaction with KSRP,
the competing interactions of DDX1 or 14–3–3 with KSRP may control
Table 2
Stress granule-associated RNA helicases.
RNA helicases Present in Relevant binding partners SG-inducing condition Note Refs
DDX1 SG YB-1, MBNL1, KSRP, PQBP1 Arsenite • DDX1 moves from nucleus to cytoplasmic SGs
upon arsenite stress
[116–118]
DDX2/eIF4A SG eIF4B Arsenite,
Hippuristanol,
Pateamine,
• Reduction of eIF4A levels and activity
induces SG formation
[121,122]





• Knockdown of DDX3 impairs SG formation
• N-terminal domain is essential for SG localization
[128,134,135,178,179]
DDX6(RCK/p54) SG, PB Ataxin 2, Ataxin 2-like Arsenite,
Heat shock







• RHAU knockdown had no effect on SG formation
• N-terminal RNA-binding domain is essential for
RHAU localization in SGs
[145]
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of its AMD activity [118]. Accordingly, this DDX1-mediated AMD reg-
ulation may play an important role during oxidative stress-induced
reprogramming of mRNA expression and cell survival decision.
3.2.2.2. DDX2/eIF4A. eIF4A, which has been extensively characterized
both biochemically and structurally, is the prototype and founding
member of theDEADboxRNAhelicase family. eIF4A is themost abundant
translation initiation factor and is required for recruitment of ribosomes
to cellular, andmost viral, mRNAs. eIF4A exists as a free form or as a sub-
unit of eIF4F, a heterotrimeric complex composed of eIF4E (them7GpppN
cap binding protein) and the scaffolding protein eIF4G. The helicase activ-
ity of eIF4A could be stimulated through transient association with eIF4B
[120]. Notably, eIF4A is one of the core constituents of SGs [88,121]. Arse-
nite, hippuristanol and pateamine exposure induced the recruitment of
eIF4A to SGs [121,122]. Interestingly, inactivation of eIF4A activities,
througheither inhibition of its RNAbindingor blockage of eIF4F assembly,
could promote SG assembly [121,122]. As numerous stress-responsive
mRNA possesses a long and structured 5′ un-translated region (UTR)
facilitating its translation by a ‘shunting’mechanism that does not require
eIF4A-dependent scanning [107,123,124], these mRNAs might be-
come preferred candidates for translation under stress when eIF4A
isinactivated. Thus, themodulation of eIF4A activity during SG assembly
may contribute to the stress-induced reprogramming of mRNA expres-
sion and cell adaption.
3.2.2.3. DDX3/DDX3X/DBX/CAP-Rf.DDX3, asmentioned above, is a ubiqui-
tously expressed DEAD box RNA helicase and a nucleo-cytoplasmic shut-
tling protein possessing RNA dependent ATPase/helicase activity [86,
125]. Recent studies have revealed the multi-facets of DDX3 in transla-
tional control [126–133]. Our previous work demonstrated that DDX3
functions as an eIF4E inhibitory protein to speciﬁcally repress cap-
dependent translation through its N-terminal eIF4E-binding consensus
38YIPPHLR44 [130]. DDX3 could thereby block the formation of pre-
initiation complex eIF4F and translation initiation [130].
Consistently, DDX3 was previously reported to localize into cyto-
plasmic SGs while overexpressed or after arsenite treatment [128,134,
135]. Our subsequent study described coordinative roles for DDX3 and
its interactions with eIF4E/PABP1 in SG assembly and stress response
[135]. A wide variety of stress stimuli, including heat shock, UV irradia-
tion, ER, oxidative and/or osmotic stress, direct DDX3 with eIF4E and
PABP1 into SGs [135]. Interestingly, DDX3 knockdown interfered with
SG assembly, led to nuclear accumulation of PABP1 and reduced cell vi-
ability following stress. Conversely, supplementation with DDX3 could
restore these defects [135]. Notably, the SG-inducing capacity of DDX3
is independent of its ATPase and helicase activities, but mapped to the
eIF4E-binding region of DDX3 [135]. Moreover, the eIF4E-binding
defective mutant DDX3 was impaired in its SG-inducing ability andprotective effect on cell survival under adverse conditions. These obser-
vations characterize DDX3 as a pivotal SG nucleating factor and illus-
trate coordinative roles for DDX3, eIF4E and PABP1 in integrating
environmental signal, mRNA translation and cellular survival under ad-
verse conditions.
3.2.2.4. DDX6 (RCK/p54/Dhh1/Me31B/Cgh-1). The humanDEAD-box RNA
helicase, DDX6, is an abundant protein found bound to non-translating
mRNA in the cytoplasm and acts as a translational repressor [136].
DDX6 is highly expressed in malignant cell lines, and its expression is
linked to the regulation of differentiation and cell growth of cancer
cells. DDX6 directly interacts with AGO1 and AGO2 in RNA-induced
silencing complex (RISC), facilitates P-bodies formation, and plays a
role in Dicer-independent miRNA processing as well as ARE-mediated
mRNA decay. Notably, DDX6 is a prototypic component of processing
bodies and localizes to SGs upon arsenite or heat shock treatment
[136–138].
Interestingly, mutagenesis of conserved DDX6 helicase motifs
relieves its suppression on translation, reduces accumulation of DDX6
in P-bodies, inhibits its capacity to assemble P-bodies and impairs its
interaction with oocyte repressor complex components [139]. More sur-
prisingly, although C-terminal D2 domain of DDX6 alone is deﬁcient for
P-body assembly, this region alone is sufﬁcient for translational repres-
sion and complete accumulation in P-bodies [139]. Thus, the D2 domain
may act as a protein binding platform, whereas the ATPase/helicase ac-
tivity allows protein complex remodeling. In addition, two of DDX6-
interacting factors, Ataxin-2 and Ataxin-2 like, are shown to regulate
P-bodies and SG assembly, supporting the importance of DDX6 in the
biogenesis of these two RNA granules [138,140]. Also noted, DDX6 was
recently shown to interact with the VEGF mRNA 5′-UTR and regulate
VEGF IRES-mediated translation under hypoxia [141]. Since SGs sequester
and inhibit VEGF transcripts during hypoxia to regulate tumor cell surviv-
al after irradiation via an unknownmechanism [142], these observations
provide evidence for the DDX6-mediated modulation of VEGF mRNA
translation and its functional consequences under hypoxic conditions.
3.2.2.5. DHX36/RHAU (RNA Helicase Associated with AU-rich element).
RHAU is a DEAH box helicase (DHX36) associatedwith AU-rich element
(ARE) of urokinase-type plasminogen activator (uPA) mRNA [143].
RHAU is a nucleocytoplasmic shuttling protein predominantly found
in the nucleus. ATPase activity is necessary for RHAU function in the
decay of uPA mRNA and for its nuclear localization [143,144]. RHAU
was reported to associate with SGs upon treatments with various stress
inducers, including arsenite, heat shock, hippuristanol and CCCP [145].
In the same study, RHAU was shown to physically interact with
RNA through a unique N-terminal RNA-binding domain composed of
a G-rich region and an RHAU-speciﬁc motif that is highly conserved be-
tween RHAUorthologs. The sameRNA-binding domain is necessary and
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RHAU is involved in the RNA interaction and in the dynamic regulation
of RHAU shuttling into and out of SGs [145]. As RHAU knockdown had
no effect on arsenite-induced SG formation, it seems that RHAU does
not participate actively in SG assembly [145]. However, considering
that RHAU is a cis-acting factor involved in ARE-mediated decay of
uPAmRNA and that its associationwith SG is regulated by RNA interac-
tion, the signiﬁcance of RHAU for SGs is proposed to associate with
mRNA turnover regulation during stress.
3.3. Multifaceted function of DExD/H RNA helicases in stress survival
regulation
As RNA remodeling enzymes, DExD/H RNA helicases have been im-
plicated in an intriguing array of cellular functions associated with RNA
metabolism. In this review, although we concentrate mainly on two
kinds of cellular stress responses (microbial pathogen-induced signaling
cascades and stress granule formation triggered by various stress stim-
uli), it is important to note that there are additional ways in which
DExD/H RNA helicases can exert their effect to regulate cellular survival
during stress.
For example, signiﬁcant attention has been focused on the
quadruplex-resolving activity of DHX36/RHAU. DHX36 has been
described to recognize and remove so-called quadruplex knots (G4-
loops) present in gene promoter regionswhere they block transcription.
The speciﬁcity of DHX36 for G4-loops is mediated by its N-terminal
RNA-binding domain rather than its helicase core region [146]. Indeed,
DHX36 has been suggested to resolve G4-loops present in the promoter
of the transcriptional regulator YY1 and to thus facilitate its transcrip-
tion [147]. Since YY1 has recently been shown to negatively regulateFig. 4. Themultifaceted role of RNA helicase DDX3 in stress survival regulation. RNA helicase DD
insults. Duringmicrobial pathogen infection,DDX3has been suggested to act as a sensor for path
as a signaling intermediate through its association with TBK1 and IKKε (b). DDX3 has been als
scriptional modulator role (c). After DNA damage, DDX3 could promote the retention and accum
ulate apoptotic signaling (d). Notably, DDX3 could interact and cooperatewith Sp1 to up-regula
function (e). Upon stimuli of various stresses, such as heat shock, UV irradiation, ER, oxidative o
could suppress apoptosis (f). Different models proposed by recent studies for the role of DDX3
could sequester eIF4E from its binding to eIF4G resulting in the ubiquitous blockage of cap-d
harboring a highly structured 5′-UTR (h); DDX3could promote 80S ribosomeassembly through
of certainmRNAs containing structures near them7GTP capmoiety (j). Considering the different
models may account for how cells reconﬁgure the proteome and determine their fate and survthe ifnb promoter, these ﬁndings may provide additional functional
link between DHX36 and anti-viral immunity [148].
In addition, roles of transcriptional co-regulator have been shown for
DDX3, DDX5 (also known as p68), DDX17 (also known as p72) and
DDX20 (also known as gemin 3), suggesting their possible involvement
in transcriptional regulation during stress response. Indeed, DDX5/p68,
an established co-activator of the p53 tumor suppressor, has recently
been shown to be required for the induction of p53-dependent p21 ex-
pression and cell cycle arrest after DNA damage, highlighting a novel
function of p68 as a modulator of the decision between p53-mediated
growth arrest and apoptosis [149].
Moreover, like DHX36, one single RNA helicase may participate in
stress response and survival regulation at multiple different levels.
Over the past few years, DDX3 has been reported to participate in vari-
ous mRNA biogenesis steps andmay serve as a typical example to illus-
tratemultifaceted function of RNA helicases in stress survival regulation
(Fig. 4). DDX3wasﬁrst identiﬁed as an interacting partner of HCV (Hep-
atitis C Virus) core protein [125,150,151]. As a member of DEAD box
RNA helicase family, DDX3 is a nucleo-cytoplasmic shuttling protein
and possesses RNA dependent ATPase/helicase activity [86,125]. Nucle-
ar export of DDX3 can be mediated not only by the CRM1-dependent
export pathway [86], but may also in part through the TAP-mediated
pathway recently [128]. Over the past few years, an array of divergent
cellular functions for DDX3 has been reported, includingmRNA splicing,
export, transport, ribosome biogenesis, as well as transcriptional and
translational regulation [115,131,152–155]. As mentioned above, during
microbial pathogen infection, DDX3 could act as a sensor for pathogen-
derived nucleic acids in conjunctionwith the RLRs (Fig. 4) [72]. Addition-
ally, DDX3 serves as a signaling intermediate through its interactionwith
TBK1 and IKKε (Fig. 4) [69,70]. Furthermore, DDX3 was recruited to theX3 has been proposed to havemultifaceted function in response to various environmental
ogen-derivednucleic acids in conjunctionwith the RLRs (a). In addition, DDX3 could serve
o demonstrated to be recruited to the IFN promoter during infections, suggesting its tran-
ulation of p53 in the nucleus probably through its interaction with p53, and thereby reg-
te the promoter activity of p21 in a p53-independentmanner to exert its tumor suppressor
r osmotic stress, DDX3 is required for the formation of cytoplasmic stress granules, which
in translation initiation may confer optimal translation of stress-responsive mRNAs: DDX3
ependent translation (g); DDX3 could promote ribosomal scanning of selected mRNAs
its associationwith eIF3 and the40S ribosomal subunit (i); DDX3 is required for translation
effects exerted byDDX3on the translation ofmRNAwith various structural features, these
ival during adverse conditions (see text).
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activation (Fig. 4) [69]. Notably, DDX3 associates with p53, increases its
accumulation, and thereby positively regulates apoptotic signaling
following DNA damage (Fig. 4) [156]. However, DDX3 could interact
and cooperate with Sp1 to up-regulate the promoter activity of p21 in a
p53-independent manner to exert its tumor suppressor function
(Fig. 4) [152]. Upon stimuli of various stresses, such as heat shock, UV
irradiation, ER, oxidative and/or osmotic stress, DDX3 is required for SG
assembly, which could suppress stress-induced apoptosis (Fig. 4) [135].
Recently, multiple functional roles for DDX3 in translational regula-
tion proposed by recent evidence may confer optimal translation of
stress-responsive mRNAs (Fig. 4): DDX3 could function as an eIF4E in-
hibitory protein to speciﬁcally repress cap-dependent translation
through its eIF4E-binding consensus motif eIF4E, and thereby block the
formation of pre-initiation complex eIF4F and translation initiation
[130]. In addition, DDX3 may preferentially promote the translation ini-
tiation of structured 5′ untranslated regions upon its RNA helicase activ-
ity [128,129]. Interestingly, DDX3 could promote 80S ribosome assembly
through its association with eIF3 and the 40S ribosomal subunit [127].
Also noted, DDX3 is required for translation of certainmRNAs containing
structures near the m7GTP cap moiety [133]. It is worthy to note that
numerous stress-responsive transcripts preferentially translated under
adverse conditions tend to initiate translation by non-canonical
mechanisms largely dependent on uORF and highly structured IRES
[104–108]. Since both uORF and IRES rely heavily on various trans-
acting factors, such as eIF3 [109], the diverse scenarios proposed for
the role of DDX3 in translation initiation of different mRNAs may sug-
gest the relevance of DDX3 in the speciﬁc and optimal translation of
stress-responsive mRNAs and subsequent survival decision during
stress. Other than DDX3, nucleic acid receptor DHX9 has been proposed
to have an additional role in regulating transcription of IFN-stimulated
genes or subsequent processing of thesemRNAs [157]. Themultifaceted
function is likely to reﬂect the fundamental roles that RNA helicases
play in response to stress. Undoubtedly, future studies will explore the
involvement and underlying mechanisms of more RNA helicases in
stress response and survival regulation.
4. Conclusions and future perspectives
The cellular mechanisms responsible for the cell survival regulation
under stress represent a complex and diverse program. Deciphering
molecules and pathways involved in ﬁne-tuning of cell demise and
cyto-protective processes upon stress stimuli is of utmost meaning in
biomedicine, since its deregulation is tightly linked to the pathogenesis
of numerous diseases, such as pathogen infections, diabetes, neurode-
generative diseases and cancer [158]. Actually, recent development
clearly demonstrates that our capability to manipulate these endoge-
nous survival programs will lead to functional treatment approaches
[158].
Notably, the requirements of precise gene regulation during stress
response must be achieved at different levels. Considering the impor-
tance of RNA processing as critical steps in gene expression, RNA
helicases are relevant and potential regulators of cellular stress re-
sponses. Indeed, as summarized in this review, these RNA remodeling
enzymes have emerged as central players orchestrating themultilayered
cellular stress responses. Due to their involvement in lots of regulatory
pathways that have direct implications in human health, RNA helicases
have gained much attention during the last few years. Mutations in
RNA helicases or alterations of their expression levels have been associ-
ated with infections, neurological disorders, cancer and aging processes
[159,160]. Several RNA helicases are also host factors required for the
replication of human pathogenic viruses [46]. Not surprisingly, these en-
zymes have been proposed as potential cellular targets for alternative
therapies whereas speciﬁc inhibitors targeting their catalytic activities
have already been developed [161]. According to recent ﬁndings
outlined here, it is quite evident that RNA helicases are capable ofperforming more than one, non-overlapping functions under normal or
stress conditions. Nevertheless, there also appear to be a variety of path-
ways by which stress-associated RNA helicases can exert their inﬂuence.
Undeniably, examples of RNA helicases involved in stress responses will
continue to expand. Although identiﬁcation of RNA helicases intimately
associated with stress response program has just emerged, numerous
fundamental questions remain unanswered. On the mechanistic side,
focused structure–function studies are needed to verify interacting part-
ners of RNAhelicases. In addition, the study of RNAhelicases in authentic
RNP complexes and their rearrangement activities during stress re-
sponse will probably become central theme. With regard to the cellular
function of RNA helicases in stress response, focus will undoubtedly be
on identiﬁcation of speciﬁc RNA targets, on elucidating pathways by
which environmental stress regulates RNA helicase activity or gene ex-
pression, on clarifying means by which these proteins are recruited to
their sites of action, and on devising mechanisms by which the physio-
logical and biochemical functions of RNA helicases are integrated.
Given that several RNAhelicases are reported to undergo posttranslation-
al modiﬁcations which provide the opportunity to directly link helicase
activity with environmental sensing-signal cascades [162], it will be rele-
vant to investigate the functional impact of post-translational modiﬁca-
tions on these events.
In this respect, alterations in post-translational modiﬁcation of RNA
helicases could also inﬂuence their localization, their associations with
partners and their impact on different cellular processes, adding more
complexity. Thus a given RNA helicase may have a pro-survival role in
some contexts whereas a death-promoting role in others. This context
dependence would obviously have paramount implications for the
consideration of RNA helicases as possible biomarkers or therapeutic
targets. Therefore, the huge spectrum of RNA helicase functions sug-
gests the requirement of more than ever a comprehensive understand-
ing of its biology before any medical application. Clearly, there is much
research to be performed in this area. In a near future, the fast-growing
ﬁeld of molecular designs and RNA technology should yield new in-
sights into the regulation exerted by RNA helicases in all aspects of
stress responses and survival program.
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